Clinical Trials Logo

Filter by:
NCT ID: NCT05951127 Active, not recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC

LEO
Start date: November 1, 2022
Phase: N/A
Study type: Interventional

At present, there are relatively clear treatment guidelines for colorectal cancer with oligometastases, while the treatment mode for resectable esophageal cancer with oligometastases is not clear and there is a lack of research results in this field. The aim of this study is to provide evidence of the optimal therapy model for the local resectable esophageal cancer with oligometastases ESCC patients, by investigating whether 2-year OS of the patients could benefit from additional local consolidative esophagectomy.

NCT ID: NCT05951114 Recruiting - Neurosurgery Clinical Trials

Post-neurosurgical Respiratory Muscle Dysfunction

Start date: July 1, 2023
Phase:
Study type: Observational

Respiratory muscle dysfunction may contribute to the development of postoperative pulmonary complications. However, it prevalence in patients receiving neurosurgery is largely unknown. Therefore, in present study, respiratory muscle function (measured by the ultrasound) and their correlation with the post-operative pulmonary complications will be analyzed.

NCT ID: NCT05951062 Completed - Hypertension Clinical Trials

Trans-theoretical Model Based Home Visiting on Medication Behavior

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

This study was a single-blinded, two-armed, randomized controlled trial comparing a medication self-management intervention to usual care for hypertensive elderly in the residential care facility. To explore the effect of stage-matched tailored education on disease management for hypertensive elderly. Patient were randomly assigned to either a 6-month trans-theoretical model-based medication management intervention group or a treatment-as-usual group. we would like to improve its adherence to the medicine prescribed by their own physician through five sessions of face-to-face interview which focused on anti-hypertensive medication-related information, the importance of medication refills, motivation, self-management and self-check skills.

NCT ID: NCT05950997 Recruiting - Clinical trials for Chronic Lymphocytic Leukemia

A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL

Start date: April 16, 2024
Phase: N/A
Study type: Interventional

This is a single-arm, prospective study to assess the efficacy and safety of acalabrutinib combined with obinutuzumab in subjects with previously untreated chronic lymphocytic leukemia.

NCT ID: NCT05950893 Recruiting - Clinical trials for Mechanical Ventilation

The Clinical Feasibility and Validity of PMIvent to Access Inspiratory Effort During Pressure Support Ventilation

Start date: March 25, 2023
Phase: N/A
Study type: Interventional

It is critical to maintain a relatively normal inspiratory effort during pressure support ventilation (PSV), the support level should be adjusted to match the patient's inspiratory effort. The inspiratory muscle pressure index (PMI) can reflect the elastic work of the respiratory system at the end of inspiration and has a significant correlation with inspiratory effort, and it has the outgoing advantages of being non-invasive and easy to obtain. Previous studies on PMI were based on physiological research and experimental conditions (PMIref), which require special pressure monitoring devices and software to collect and measure airway pressure. If PMI is going to be used in clinical practice, it is necessary to find a simple measurement method of PMI to replace PMIref. Most ventilators have airway pressure monitoring and end-inspiratory holding functions, and PMI can be measured by freezing the ventilator screen (PMIvent). The overall aim of this study was to determine PMIvent's clinical feasibility and validity for accessing inspiratory effort during PSV.

NCT ID: NCT05950815 Recruiting - Clinical trials for Advanced Solid Tumor

A Study of PM1015 in Patients With Advanced Solid Tumors

Start date: May 10, 2022
Phase: Phase 1
Study type: Interventional

PM1015 is a specific antibody targeting CD73. This is a phase I study to evaluate the efficacy and safety of PM1015 in patients with advanced solid tumor.

NCT ID: NCT05950763 Enrolling by invitation - Peer Influence Clinical Trials

The Causes of Academic Excellence Concentrated in Dormitory

Start date: April 27, 2023
Phase:
Study type: Observational

This research will take the sophomore to senior students of Zhejiang University of Traditional Chinese Medicine as the research object to investigate the influence of dormitory atmosphere on the academic performance, scientific research achievements, and competition awards of dormitory members, analyze the path of straightforward-A student dormitory formation, and find out the current Weak links of college students' ideological and political education in dormitory culture construction, and explore how dormitory culture construction can promote the common progress of dormitory members

NCT ID: NCT05950646 Recruiting - Dexmedetomidine Clinical Trials

Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality

Start date: November 1, 2023
Phase: Phase 4
Study type: Interventional

Sleep disturbances are prevalent in older patients with osteoarthrosis or fracture who are scheduled for knee or hip replacement surgery. The occurrence of sleep disturbances is associated with worse outcomes including increased risk of delirium and cardiac events, and worsened functional recovery. Dexmedetomidine is a highly selective α2-adrenergic agonist with sedative, anxiolytic, and analgesic properties. It exerts sedative effects via activating the endogenous sleep pathways and produces a state like non-rapid eye movement sleep, which is different from opioid- and benzodiazepine-induced sedation. Esketamine is a N-methyl-D-aspartic acid receptor antagonist and has been used as an anesthetic and analgesic. Recent studies showed that low-dose esketamine has anti-depressive and sleep-promoting effects. The investigators suppose that mini-dose dexmedetomidine-esketamine combined infusion at night can improve perioperative sleep quality in patients scheduled for knee or hip replacement surgery.

NCT ID: NCT05950516 Not yet recruiting - Type 2 Diabetes Clinical Trials

Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes

Start date: July 10, 2023
Phase: Phase 3
Study type: Interventional

To evaluate the similarity of the efficacy and safety of semaglutide injection (QLG2065) vs. Ozempic® in patients with type 2 diabetes mellitus (T2DM) with poor blood glucose control after metformin treatment.

NCT ID: NCT05950490 Recruiting - Clinical trials for Primary Vitreoretinal Lymphoma

Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma

Start date: October 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study intends to apply for the establishment of research beds, establish a Chinese PVRL research cohort, and carry out a to achieve the following research objectives: The goal of this prospective observational study is to construct the diagnosis and treatment system for primary vitreoretinal lymphoma(PVRL). The study is to achieve the following research objectives: 1. To establish a comprehensive diagnostic criteria for PVRL with high diagnostic efficiency and strengthen the PVRL diagnostic system; 2. To establish a standardized treatment pathway for PVRL and evaluate the efficacy and safety of treatment; 3. To screen the prognosis evaluation indicators, and to establish the follow-up process and prognosis evaluation system of PVRL; 4. To explore the pathogenesis of PVRL, specific tumor markers and drug therapeutic targets.